Clinical evaluation of incadronate in korean patients with malignancy-associated hypercalcemia: An open-label, multicenter study

Abstract BACKGROUND: Incadronate has been found to lessen the increase in corrected serum calcium levels in malignancy-associated hypercalcemia (MAH) in a Phase III study in Japan. The drug is currently used to treat MAH in Japan. OBJECTIVE: The purpose of this study was to assess the clinical usefu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kim, Sung-Bae, Lee, Jung Shin, Kim, Heung Tae, Im, Yong Hyuck, Kim, Tae Won, Ryoo, Baek Yeol, Park, Yeon Hee, Park, Joon Oh, Park, Keunchil, Katoh, Hitoshi, Yamamoto, Minoru
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2007
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3967285/
https://ncbi.nlm.nih.gov/pubmed/24683210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2007.06.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados